Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Nymox Pharmaceutical Corporation NYMX is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.20 million. The trailing-twelve-month return on investment at Meridian Bioscience, Inc. VIVO is 21.70%. Meridian Bioscience's PEG ratio is 1.88. The trailing-twelve-month return on investment at SurModics, Inc. SRDX is 11.20%. SurModics' EPS for the same period is $0.88. The trailing-twelve-month return on investment at Neogen Corp. NEOG is 9.30%. Neogen's profit margin for the same period is 11.60%.